In partnership with Mergermarket, an Acuris company
Whether digital or pharmaceutical, technology is where it's at right now. As M&A value sinks to pre-pandemic levels, the TMT and PMB sectors between them are carrying much of the AMERS market. With volume also falling for four successive quarters, we all want to know: where is the bottom?
2023 - a pivotal year?
Besides the relatively strong activity around tech and pharma, there’s resilience too in both business and financial services. And, despite a 22% fall in private equity fundraising, there are still vast stores of dry powder waiting for the right time to deploy.
In our Deal Drivers AMERS 2023 Outlook, produced with Mergermarket, we look ahead to see if the worst is behind us. Follow our heat map of prospective deals across the Americas, and discover our predicted trends for the coming year. Though 2023 is set to be another challenging time, there is now light at the end of the tunnel.
Find out more – get the report.
Deal Drivers: AMERS 2023 Outlook explores activities and outlook for the following regions:
- Western US
- Midwestern US
- Southern US
- Northeastern US
- Latin America & the Caribbean